# Cullinan Therapeutics, Inc. (CGEM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CGEM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -103.37M | $ -84.26M | $ 2.07M | $ 321.75M |
| 2025 | $ 0 | $ -225.14M | $ -180.00M | $ 2.68M | $ 408.73M |
| 2024 | $ 0 | $ -175.93M | $ -152.72M | $ 2.15M | $ 590.33M |
| 2023 | $ 0 | $ -165.61M | $ -145.41M | $ 3.59M | $ 453.70M |
| 2022 | $ 0 | $ 124.24M | $ -142.76M | $ 5.19M | $ 535.03M |
| 2021 | $ 22.52M | $ -77.94M | $ -51.63M | $ 0 | $ 424.97M |
| 2020 | $ 0 | $ -65.99M | $ -37.94M | $ 0 | $ 199.01M |
| 2019 | $ 0 | $ -26.66M | $ -27.00M | $ 0 | $ -40.77M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.13 |
| Current Ratio | 8.42 |

## Other views

- [Metrics](https://sponda.capital/en/CGEM.md)
- [Charts](https://sponda.capital/en/CGEM/charts.md)
- [Compare](https://sponda.capital/en/CGEM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.